Thermo Fisher to Offer Senior Notes

The firm has yet to provide an estimated amount of proceeds from the notes offerings, which will help pay for its $2.1 billion acquisition of Dionex.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories